Healing Category
THE FAT MOBILIZER
hGH Fragment 176-191
AOD-9604 is a small fragment of human growth hormone that was isolated specifically for its fat-burning properties. Unlike full HGH, it doesn't affect blood sugar or cause tissue growth. It just targets fat cells. It works by flipping the switch from "store fat" to "burn fat" and has also shown promise for cartilage and bone repair.
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
No. This profile records AOD-9604 as not FDA approved and for research use only.
Review the regulatory and source details on this page for the current context.
Dose: 250-300 mcg daily (once or twice).
Schedule: daily. Cycle: 6 weeks on, 2 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
This guide links to 2 curated or current research sources.
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Review the AOD-9604 research sourcesReported side effects of AOD-9604 include Mild water retention, Headache, and Injection site irritation.
They are reported or occasional reactions, not a prediction of what any one person will experience.
AOD-9604 has an editorial safety grade of A (Excellent Safety).
FDA GRAS (Generally Recognized As Safe) status. One of the safest peptides available. Safety depends on dose, sourcing, health history and medical supervision, so this page does not call it safe for personal use.
Activates lipase enzymes to break down stored fat
Inhibits the enzyme that stores new fat
Increases thermogenesis and metabolic rate
May support bone and cartilage regeneration
AOD-9604 appears in work by Frank Ng and colleagues at Monash University published in 2000 and 2001. Those papers studied a synthetic analogue based on the C-terminal region of human growth hormone and compared it with intact growth hormone in animal experiments. This is the research lineage of AOD-9604, without treating every growth-hormone fragment as the same molecule.
[Ng and colleagues, AOD9604 study, 2000](https://pubmed.ncbi.nlm.nih.gov/11146367/)
[Monash AOD9604 study, 2001](https://pubmed.ncbi.nlm.nih.gov/11713213/)
People looking to lose stubborn body fat · Those wanting GH benefits without side effects · Athletes needing joint and cartilage support · Anyone with slow metabolism or weight plateau · Osteoarthritis sufferers
In-stock prices from 125 vendors, checked Oct 14, 2026.
Market evidence
We found certificates from some of the AOD-9604 vendors we track. Based on the certificates our crawler found; vendors may publish more than we index. Research on this page describes the molecule. Vendor certificates concern particular market samples or batches; they do not change the research evidence or establish clinical safety, sterility, or suitability for use.
Certificate assessment
5 evaluated certificates
5 graded · 0 not graded · 2 in the A range.
Each result belongs to the named vendor’s certificate. Grades assess the document and its reported tests, not the vendor’s whole catalog or the safety of a product.
Automated checks can make mistakes. Open “Why this result?” for the reason and any review notice, and check the linked COA’s lot against your product. How grading works
5 evaluated records
Document grade
X2: The certificate's identity evidence (IDENTITY: AOD-9604) can't confirm the peptide on its own; that needs mass spectrometry or a side-by-side match to a reference standard.
Document check: fail.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
ARC-A010-001
Document grade
B2: Identity, purity and amount are supported, and the lab's own records match this certificate.
Document check: flag.
Lab record: matched.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
CPACD10AP26208
Document grade
Review required
B3: Most of the evidence is there, but printed identity identifiers need review, so the grade stops at A-.
Document check: flag.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
TWA-26-PKITS03
Document grade
C10: No endotoxin (bacterial toxin) test is reported, and an injectable needs one, so the grade stops at D.
Document check: flag.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
a52026
Document grade
Review required
C4: Tested by the seller or manufacturer itself, not an independent lab.
Document check: fail.
Lab record: not confirmed.
Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2
AOD02132024
| COA grade | Printed lab | Certificate | |||
|---|---|---|---|---|---|
| Valor Peptides Lot: ARC-A010-001 | Document grade Why this result?X2: The certificate's identity evidence (IDENTITY: AOD-9604) can't confirm the peptide on its own; that needs mass spectrometry or a side-by-side match to a reference standard. Document check: fail. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Accumark Labs | Aug 18, 2026 | 99.19%99.0–99.49% | View COA |
| Coffee & Peppers Lot: CPACD10AP26208 | Document grade Why this result?B2: Identity, purity and amount are supported, and the lab's own records match this certificate. Document check: flag. Lab record: matched. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Freedom Diagnostics | Jul 31, 2026 | 99.75%99.5%+ | View COA |
| pepkits Lot: TWA-26-PKITS03 | Document grade Review required Why this result?B3: Most of the evidence is there, but printed identity identifiers need review, so the grade stops at A-. Document check: flag. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Tidewater Analytical | Apr 16, 2026 | 98.63%Under 99% | View COA |
| LiveWell Peptides Lot: a52026 | Document grade Why this result?C10: No endotoxin (bacterial toxin) test is reported, and an injectable needs one, so the grade stops at D. Document check: flag. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | MZ Biolabs | Jan 8, 2026 | 99.96%99.5%+ | View COA |
| Skye Peptides Lot: AOD02132024 | Document grade Review required Why this result?C4: Tested by the seller or manufacturer itself, not an independent lab. Document check: fail. Lab record: not confirmed. Graded Oct 14, 2026 · Grader 0.4.9 · Policy 2026-10-07.2 | Not reported | Feb 15, 2024Older record | 99.8%99.5%+ | View COA |
The clinic network
Request a free connection to a peptide clinic, by telehealth or in person. A licensed clinician decides whether any treatment is right for you. What peptide therapy involves
Boost metabolism and burn fat without changing your diet
from $0.90/mg · 121 vendorsNº 001 / 006Short-acting GH pulse boost timed to your body's natural rhythm
from $2.65/mg · 96 vendorsNº 002 / 006Pure growth hormone boost without the unwanted side effects.
from $1.80/mg · 121 vendorsNº 003 / 006Exercise in a peptide. Boost metabolism without the treadmill
from $1.20/mg · 174 vendorsNº 004 / 006Triple-action peptide with 24% average weight loss in trials.
from $1.70/mg · 336 vendorsNº 005 / 006FDA-approved GHRH analog that reduces stubborn visceral fat
from $2.75/mg · 152 vendorsNº 006 / 006
